Literature DB >> 20358297

ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.

Elif Akisik1, Hulya Yazici, Nejat Dalay.   

Abstract

Genetic factors that contribute to the risk of breast cancer are largely not known and association studies have revealed several genes with low penetrance risk alleles for breast cancer. Analysis of these genes may provide important information on the risk factors affecting carcinogenesis. Variations in the ARLTS1, RAD51 and MDM2 genes have been associated with increased risk of different cancer types but for breast cancer the results are not consistent. In this study we investigated the role of the allelic variants in candidate genes acting in the tumor suppressor, DNA repair and p53 pathways as risk factors for familial breast cancer in 147 patients displaying characteristics of familial disease. Presence of the polymorphic variants were investigated by amplification of the corresponding regions and restriction fragment length polymorphism analysis. Genotype and allele frequencies in the patients were significantly different for all three variants. Our results indicate that the polymorphic variants might affect individual susceptibility towards breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20358297     DOI: 10.1007/s11033-010-0113-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  46 in total

1.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

Authors:  A A Davies; J Y Masson; M J McIlwraith; A Z Stasiak; A Stasiak; A R Venkitaraman; S C West
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

2.  ARLTS1 variants and risk of colorectal cancer.

Authors:  Bernd Frank; Kari Hemminki; Hermann Brenner; Michael Hoffmeister; Jenny Chang-Claude; Barbara Burwinkel
Journal:  Cancer Lett       Date:  2006-02-20       Impact factor: 8.679

3.  Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.

Authors:  M T Voso; E Fabiani; F D'Alo'; F Guidi; A Di Ruscio; S Sica; L Pagano; M Greco; S Hohaus; G Leone
Journal:  Ann Oncol       Date:  2007-09       Impact factor: 32.976

4.  Familial cancer associated with a polymorphism in ARLTS1.

Authors:  George Adrian Calin; Francesco Trapasso; Masayoshi Shimizu; Calin Dan Dumitru; Sai Yendamuri; Andrew K Godwin; Manuela Ferracin; Guido Bernardi; Devjani Chatterjee; Gustavo Baldassarre; Shashi Rattan; Hansjuerg Alder; Hideaki Mabuchi; Takeshi Shiraishi; Lise Lotte Hansen; Jens Overgaard; Vlad Herlea; Francesca Romana Mauro; Guillaume Dighiero; Benjamin Movsas; Laura Rassenti; Thomas Kipps; Raffaele Baffa; Alfredo Fusco; Masaki Mori; Giandomenico Russo; Chang-Gong Liu; Donna Neuberg; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

5.  MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.

Authors:  Gareth L Bond; Kim M Hirshfield; Tomas Kirchhoff; Gabriella Alexe; Elisabeth E Bond; Harlan Robins; Frank Bartel; Helge Taubert; Peter Wuerl; William Hait; Deborah Toppmeyer; Kenneth Offit; Arnold J Levine
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

6.  MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.

Authors:  Marijke Wasielewski; Jord H A Nagel; Cecile Brekelmans; Jan G M Klijn; Ans van den Ouweland; Hanne Meijers-Heijboer; Mieke Schutte
Journal:  Breast Cancer Res Treat       Date:  2006-11-02       Impact factor: 4.872

7.  DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study.

Authors:  Varinderpal S Dhillon; Eric Yeoh; Michael Fenech
Journal:  Urol Oncol       Date:  2009-11-13       Impact factor: 3.498

8.  Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice.

Authors:  Sergey G Kuznetsov; Diana C Haines; Betty K Martin; Shyam K Sharan
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

9.  Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers.

Authors:  Ellen R Copson; Helen E White; Jeremy P Blaydes; David O Robinson; Peter W Johnson; Diana M Eccles
Journal:  BMC Cancer       Date:  2006-03-24       Impact factor: 4.430

10.  MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.

Authors:  Fiona E M Paulin; Mary O'Neill; Gillian McGregor; Andrew Cassidy; Alison Ashfield; Clinton W Ali; Alastair J Munro; Lee Baker; Colin A Purdie; David P Lane; Alastair M Thompson
Journal:  BMC Cancer       Date:  2008-10-01       Impact factor: 4.430

View more
  16 in total

1.  Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis.

Authors:  Wei Li; Ke-Jia Liu; Jing-Song Song; Rui Song; Zi-Liang Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.

Authors:  Erjiang Zhao; Dan Cui; Ling Yuan; Weiquan Lu
Journal:  Mol Biol Rep       Date:  2011-07-03       Impact factor: 2.316

3.  Co-expression of Oct-4 and Nestin in human breast cancers.

Authors:  Caigang Liu; Xuezhao Cao; Yanjun Zhang; Hong Xu; Ruishan Zhang; Yunfei Wu; Ping Lu; Feng Jin
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

4.  Lack of an Association between a Functional Polymorphism in the MDM2 Promoter and Breast Cancer in Women in Northeast Iran.

Authors:  Zeinab Tavakkol Afshari; Amin Reza Nikpoor; Jalil Tavakkol Afshari; Rashin Ganjali; Parvaneh Sanglakh Ghoochan Atigh; Fatemeh Homaei Shandiz; Khadijeh Jamialahmadi
Journal:  Rep Biochem Mol Biol       Date:  2017-10

5.  TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Jing-Jun Wang; Yuan Zheng; Liang Sun; Li Wang; Peng-Bo Yu; Jian-Hua Dong; Lei Zhang; Jing Xu; Wei Shi; Yu-Chun Ren
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

6.  An association between the -41657 C/T polymorphism of X-ray repair cross-complementing 2 (XRCC2) gene and ovarian cancer.

Authors:  Magdalena M Michalska; Dariusz Samulak; Beata Smolarz
Journal:  Med Oncol       Date:  2014-10-30       Impact factor: 3.064

7.  Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study.

Authors:  Renata Krupa; Tomasz Sliwinski; Maria Wisniewska-Jarosinska; Jan Chojnacki; Maja Wasylecka; Lukasz Dziki; Jan Morawiec; Janusz Blasiak
Journal:  Mol Biol Rep       Date:  2010-11-20       Impact factor: 2.316

8.  Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.

Authors:  Wijden Mahfoudh; Noureddine Bouaouina; Slim Ben Ahmed; Sallouha Gabbouj; Jingxuan Shan; Rebecca Mathew; Nancy Uhrhammer; Yves-Jean Bignon; Wafa Troudi; Amel Ben Ammar Elgaaied; Elham Hassen; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

9.  RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.

Authors:  Deepa Sekhar; Singh Pooja; Sandeep Kumar; Singh Rajender
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

10.  Association of polymorphisms in the 5' untranslated region of RAD51 gene with risk of endometrial cancer in the Polish population.

Authors:  Magdalena M Michalska; Dariusz Samulak; Hanna Romanowicz; Beata Smolarz
Journal:  Arch Gynecol Obstet       Date:  2014-06-15       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.